This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against coronavirus infection and inducing effective coronavirus antigen-specific immune responses such as antibody and/or T cell responses. Specifically, in one embodiment, the present disclosure relates to methods comprising administering to a subject RNA encoding a peptide or protein comprising an epitope of SARS-CoV-2 spike protein (S protein) for inducing an immune response against coronavirus S protein, in particular S protein of SARS-CoV-2, in the subject, i.e., vaccine RNA encoding vaccine antigen.
本公开涉及预防或治疗冠状病毒感染的 RNA 领域。特别是,本公开涉及接种疫苗预防冠状病毒感染和诱导有效的冠状病毒抗原特异性免疫应答(如
抗体和/或 T 细胞应答)的方法和制剂。具体地说,在一个实施方案中,本公开涉及的方法包括向受试者施用编码包含
SARS-CoV-2尖峰蛋白(S蛋白)表位的
多肽或蛋白质的RNA,以诱导受试者对冠状病毒S蛋白,特别是
SARS-CoV-2的S蛋白产生免疫应答,即编码疫苗抗原的疫苗RNA。